XML 54 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Segment and Related Information (Tables)
12 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense The Company evaluates segment performance based on income (loss) before interest income and other income and expense.

 

 

Diagnostics

 

 

Other

 

 

Total

 

Year ended June 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

593.5

 

 

$

45.1

 

 

$

638.6

 

Depreciation and amortization

 

 

68.2

 

 

 

3.8

 

 

 

72.0

 

Segment operating loss

 

 

(82.4

)

 

 

(149.3

)

 

 

(231.7

)

Year ended June 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

789.4

 

 

$

61.7

 

 

$

851.1

 

Depreciation and amortization

 

 

67.7

 

 

 

5.3

 

 

 

73.0

 

Segment operating income (loss)

 

 

133.3

 

 

 

(125.7

)

 

 

7.6

 

Year ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

690.4

 

 

$

53.3

 

 

$

743.7

 

Depreciation and amortization

 

 

49.2

 

 

 

5.2

 

 

 

54.4

 

Segment operating income (loss)

 

 

142.6

 

 

 

(20.7

)

 

 

121.9

 

 

 

 

Years Ended June 30,

 

 

 

2020

 

 

2019

 

 

2018

 

Total operating income (loss) for reportable segments

 

$

(231.7

)

 

$

7.6

 

 

$

121.9

 

Unallocated amounts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

3.0

 

 

 

3.2

 

 

 

1.8

 

Interest expense

 

 

(10.8

)

 

 

(12.0

)

 

 

(3.2

)

Other

 

 

16.2

 

 

 

1.2

 

 

 

(0.4

)

Income (loss) from operations before income taxes

 

 

(223.3

)

 

 

 

 

 

120.1

 

Income tax benefit

 

 

(23.7

)

 

 

(4.4

)

 

 

(13.0

)

Net income (loss)

 

 

(199.6

)

 

 

4.4

 

 

 

133.1

 

Net loss attributable to non-controlling interest

 

 

(0.1

)

 

 

(0.2

)

 

 

(0.2

)

Net income (loss) attributable to Myriad Genetics, Inc.

   stockholders

 

$

(199.5

)

 

$

4.6

 

 

$

133.3

 

Schedule Of Comparison of Balance Sheet Assets by Operating Segment

The following table sets forth a comparison of balance sheet assets by operating segment:

 

 

 

June 30,

 

 

 

2020

 

 

2019

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

Diagnostics

 

$

23.9

 

 

$

25.7

 

Other

 

 

13.1

 

 

 

31.6

 

Total

 

$

37.0

 

 

$

57.3

 

Total Assets:

 

 

 

 

 

 

 

 

Diagnostics

 

$

1,002.8

 

 

$

1,215.6

 

Other

 

 

147.0

 

 

 

155.3

 

Total

 

$

1,149.8

 

 

$

1,370.9

 

Summary of Assets by Geographical Region

The following table reconciles assets by geographical region:

 

 

 

June 30,

 

 

 

2020

 

 

2019

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

United States

 

$

35.4

 

 

$

36.0

 

Rest of world

 

 

1.6

 

 

 

21.3

 

Total

 

$

37.0

 

 

$

57.3

 

Total Assets:

 

 

 

 

 

 

 

 

United States

 

$

1,097.2

 

 

$

1,265.8

 

Rest of world

 

 

52.6

 

 

 

105.1

 

Total

 

$

1,149.8

 

 

$

1,370.9

 

Reconciliation of Assets by Operating Segment and Geographic Region to Total Assets

The following table reconciles assets by operating segment and geographic region to total assets:

 

 

 

June 30,

 

 

 

2020

 

 

2019

 

Total assets by segment and geographical region

 

$

1,149.8

 

 

$

1,370.9

 

Cash, cash equivalents, and marketable investment

   securities (1)

 

 

254.8

 

 

 

191.8

 

Total

 

$

1,404.6

 

 

$

1,562.7

 

 

(1)

The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments.